| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Nov―28 |
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management |
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, Nonkululeko Avril Mbatha, Tambwe Willy Muzumbukilwa, Mukanda Gedeon Kadima, et al. (+9) Fave Yohanna Tata, Mthokosizi Bongani Nxumalo, Riziki Ghislain Manimani, Ntabaza Ndage, Bakari Salvius Amuri, Kahumba Byanga, Manimbulu Nlooto, Rene B. Khan, Hezekiel M. Kumalo |
| 2 |
[GO] |
2024―Aug―19 |
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease |
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, Maida Shahid, Taseer Ahmad |
| 3 |
[GO] |
2024―Jan―24 |
Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review |
Ilaria De Benedetto, Silvia Corcione, Carlotta Giambra, Matteo Ferrante, Simone Mornese Pinna, Elisa Zanotto, et al. (+11) Alice Palermiti, Francesca Sidoti, Luca Scaglione, Cecilia Grosso, Martina Billi, Tommaso Lupia, Sara Soloperto, Jessica Cusato, Cristina Costa, Antonio D’Avolio, Francesco Giuseppe De Rosa |
| 4 |
[GO] |
2023―Nov―08 |
Considerations of Nystatin Roll in Oral Candidiasis Scenario and the COVID-19 Pandemic-A Review |
Michelle Maria Gonçalves Barão de Aguiar, Renata Miliani Martinez, André Rolim Baby, Cristina Helena dos Reis Serra |
| 5 |
[GO] |
2023―Jan―10 |
SARS-CoV-2 Mpro Inhibitors: Achieved Diversity, Developing Resistance and Future Strategies |
Conrad Fischer, Jenson R. Feys |
| 6 |
[GO] |
2022―Nov―21 |
Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants |
Waseem Ahmad Ansari, Mohd Aamish Khan, Fahmina Rizvi, Kajim Ali, Mohd Kamil Hussain, Mohammad Saquib, Mohammad Faheem Khan |
| 7 |
[GO] |
2022―Aug―19 |
A Computational Approach for Molecular Characterization of Covaxin (BBV152) and Its Ingredients for Assessing Its Efficacy against COVID-19 |
Atala B. Jena, Asim K. Duttaroy |
| 8 |
[GO] |
2022―Aug―01 |
Pandemic Preparedness: The Potential Advantage of Medicines That Prevent Acute Side Effects of Vaccination, SARS-CoV-2 as an Example |
Pantea Kiani, Jessica Balikji, Johan Garssen, Joris C. Verster |
|
